Enrique Poradosu is Chief Science & Business Off of Nuvectis Pharma, Inc.. Currently has a direct ownership of 1.51 Million shares of NVCT, which is worth approximately $7.56 Million. The most recent transaction as insider was on Nov 19, 2024, when has been sold 2,000 shares (Common Stock) at a price of $4.99 per share, resulting in proceeds of $9,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.51M
0.13% 3M change
9.64% 12M change
Total Value Held $7.56 Million

Enrique Poradosu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2024
BUY
Open market or private purchase
$9,980 $4.99 p/Share
2,000 Added 0.13%
1,506,319 Common Stock
May 10 2024
BUY
Open market or private purchase
$3,145 $6.29 p/Share
500 Added 0.03%
1,504,319 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
130,000 Added 7.96%
1,503,819 Common Stock
Mar 27 2023
BUY
Open market or private purchase
$5,775 $11.55 p/Share
500 Added 0.04%
1,373,819 Common Stock
Jan 12 2023
BUY
Grant, award, or other acquisition
-
115,000 Added 7.73%
1,373,319 Common Stock
May 12 2022
BUY
Open market or private purchase
$10,318 $15.4 p/Share
670 Added 0.05%
1,258,319 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
60,000 Added 4.55%
1,257,649 Common Stock
Feb 07 2022
BUY
Open market or private purchase
$3,104 $3.88 p/Share
800 Added 0.07%
1,197,649 Common Stock, par valu...
Feb 04 2022
BUY
Open market or private purchase
$12,730 $3.35 p/Share
3,800 Added 0.32%
1,196,849 Common Stock, par valu...
EP

Enrique Poradosu

Chief Science & Business Off
Fort Lee, NJ

Track Institutional and Insider Activities on NVCT

Follow Nuvectis Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCT shares.

Notify only if

Insider Trading

Get notified when an Nuvectis Pharma, Inc. insider buys or sells NVCT shares.

Notify only if

News

Receive news related to Nuvectis Pharma, Inc.

Track Activities on NVCT